Novo Nordisk
Novo Nordisk has 6 source-linked AI deployments documented in AIUseCaseHub, across 2 industries and 2 countries. Key partners include EY, MIT, NVIDIA.
Hyperscaler mix
See whether Novo Nordisk's cases are powered by Microsoft, AWS, GCP, or multiple providers.
How Novo Nordisk builds AI
Build / Buy / Compose across this company's documented cases
6 of 6 cases classified (100%) · Compare all use-case types
Evidence persistence
3 of 3 judgeable cases are still publicly referenced · 3 show the organization expanding AI use.
Durability of public evidence, not whether systems remain in production. How this is measured →
Technology snapshot
What Novo Nordisk uses across visible cases
Capability flags and technologies mentioned in the indexed use cases on this page.
- Top use case
- Vision
- Tagged cases
- 2/6
- Tech names
- 23
All Use Cases (6)
Novo Nordisk Uses ML for Computer Vision to Optimize Pharmaceutical Manufacturing on AWS
Novo Nordisk A/S uses computer vision and machine learning on AWS to automate manufacturing quality tasks such as cartridge counting and anomaly detection for agar plates.The company built a prototyping solution to train, deploy, monitor, and manage ML models for edge devices and to support regulated pharmaceutical operations.
Novo Nordisk Scales to 2,500+ Use Cases with Secure Generative AI Using Amazon Bedrock
Novo Nordisk, a multinational pharmaceutical company based in Denmark, wanted to democratize employee innovation by enabling secure and compliant use of generative AI in nonregulated processes.They developed a self-service generative AI platform on AWS using Amazon Bedrock, DynamoDB, and AWS Lambda, enabling employees to build, customize, and share chatbots.The solution reduced innovation cycle time from months to days and lowered operational costs, resulting in over 25,000 employees creating chatbots for more than 2,500 use cases across various workflows.
MicrosoftNovo Nordisk transforms drug development with AI integration
Novo Nordisk, a global pharmaceutical leader, is revolutionizing drug development through strategic integration of AI and advanced analytics. Spearheaded by Dr. Faisal M. Khan, the company's corporate vice president of AI and analytics, Novo Nordisk leverages partnerships with Valo Health, Microsoft, MIT, and NVIDIA. They invest heavily in AI talent, infrastructure, and the establishment of innovation hubs such as the national AI Innovation Centre in Denmark and a new AI research hub in London. Key AI applications include accelerating the identification of drug candidates for chronic diseases and designing personalized treatment plans to improve patient outcomes. Infrastructure improvements include leveraging Microsoft's cloud technology for scaled computational power and NVIDIA hardware for supercomputing. Challenges include managing vast data, navigating complex regulations, and attracting top AI talent. The company remains committed to advancing global collaborations and ensuring sustainable, renewable-powered data center operations for long-term pharmaceutical innovation.
MicrosoftNovo Nordisk Advances Drug Discovery Using Microsoft AI
Novo Nordisk established a platform-based collaboration with Microsoft to incorporate Azure AI and computational services into its drug-discovery processes. This partnership aims t...
MicrosoftNovo Nordisk transforms shop floor manufacturing and training with augmented reality
Novo Nordisk, a Denmark-based global pharmaceutical company, introduced Microsoft HoloLens 2 and Microsoft Power Platform to revolutionize its manufacturing processes. The use of HoloLens 2 augmented reality instructions, combined with Dynamics 365 Remote Assist and Dynamics 365 Guides, enabled shop floor workers to undergo hands-free, step-by-step, 3D visualized training and operational tasks. This innovation improved onboarding speed, process accuracy, and ensured compliance with strict Good Manufacturing Practices. Remote Assist functionality facilitated virtual site visits and faster troubleshooting, eliminating delays due to waiting for on-site engineers. Employees provided feedback to refine the augmented instructions, which fostered a culture of continuous improvement and flexibility. Over 1,000 employees participated in the pilot, showing high engagement and willingness to innovate. The project helped Novo Nordisk improve consistency, efficiency, and process reliability, driving the digital transformation of pharmaceutical manufacturing.Employees faced complex manufacturing procedures, compliance obligations, and required more effective onboarding methods. The solution was rigorously evaluated for regulatory compliance and proved to enhance day-to-day operations as well as employee motivation.
Dow and Novo Nordisk Boost Productivity with Smart Factory Innovations
The article provides an overview of Industry 4.0 in manufacturing, highlighting the real-world application of Microsoft technologies like AI, IoT, and cloud solutions. It discusses how leading manufacturers such as Dow and Novo Nordisk are leveraging these technologies to innovate factories and warehouses, increasing automation, predictive maintenance, and operational efficiency. The text also examines the broader historical context of industrial revolutions, focusing on today’s digital transformation powered by cloud-based data, digital twins, and machine learning. Dow utilized Microsoft AI solutions to break down data silos, boosting equipment uptime and production efficiency, while Novo Nordisk applied mixed reality on the shop floor to optimize processes. Stanley Black & Decker is briefly mentioned as benefiting from IoT sensor integration for improved machine insights. The article outlines the benefits as well as the implementation challenges, such as systems integration, skills gaps, cybersecurity, and managing big data. It features practical examples, though not with deep technical architectural detail, and projects a vision where AI and Microsoft cloud solutions are at the heart of smarter manufacturing.